ME/CFS Research Foundation Logo

Clinical research – Interventional – Clinical trial phase II

Description

Interventional clinical research that follows successful phase I trials. For drugs or treatments already approved for other diseases, phase II usually follows successful case reports/series. It involves a larger number of individuals and evaluates treatment efficacy as well as potential side effects. (Description adapted from: https://www.aerzteblatt.de/archiv/64080/Studientypen-in-der-medizinischen-Forschung)

Research projects (4)
Research areas (10)
Research networks (2)
Working groups (4)
People (7)
Publications (1)

Research projects

Immunoadsorption in Patients With Chronic Fatigue Syndrome Including Patients With Post-COVID-19 CFS (IA-PACS-CFS)
Project status:
Ongoing
Country:
Germany
Principal investigator:
Harald Pruess
Organisations:
Charité – University Medicine Berlin, German Center for Neurodegenerative Diseases (DZNE)
Research period:
2023-10-01
to 2025-02-28
Research types:
Clinical research
Research areas:
Immunological dysfunction
Immunoadsorption vs Sham Treatment in Post-COVID-19 Patients With Chronic Fatigue Syndrome (EXTINCT post COVID)
Project status:
Ongoing
Country:
Germany
Principal investigator:
Vega Goedecke
Organisations:
Hannover Medical School (MHH)
Research period:
2023-07-01
to 2025-06-30
Research types:
Clinical research
Research areas:
Immunological dysfunction
Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS) (PoCoVIT)
Project status:
Ongoing
Country:
Germany
Principal investigator:
Christiana Franke
Organisations:
Charité – University Medicine Berlin
Research period:
2023-10-01
to 2025-03-31
Research types:
Clinical research
Research areas:
Immunological dysfunction, Nervous system disorder
Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo in Participants With Post-COVID-19 Syndrome (VERI-LONG)
Project status:
Ongoing
Country:
Germany
Principal investigator:
Judith Bellmann-Strobl
Organisations:
Charité – University Medicine Berlin, Max Delbrück Center (MDC)
Research period:
2023-02-01
to 2024-12-31
Research types:
Clinical research
Research areas:
Cardiovascular dysfunction